Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by KIMMEL, C. A.
Right arrow Articles by FRANCIS, E. Z.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KIMMEL, C. A.
Right arrow Articles by FRANCIS, E. Z.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 Oxford University Press

other

Proceedings of the Workshop on the Acceptability and Interpretation of Dermal Developmental Toxicity Studies1

CAROLE A. KIMMEL* and ELAINE Z. FRANCIS{dagger},2

*Reproductive and Developmental Toxicology Branch, HHAG/OHEA/ORD Washington, DC. 20460 {dagger}Health and Environmental Review Division/OTS/OPTS, U.S. Environmental Protection Agency Washington, DC. 20460

Received August 2, 1989; accepted August 10, 1989

Proceedings of the Workshop on the Acceptability and Interpretation of Dermal Developmental Toxicity Studies. KIMMEL, C. A., AND FRANCIS, E. Z. (1990). Fundam. Appl. Toxicol 14, 386–398. The workshop on The Acceptability and Interpretation of Dermal Developmental Toxicity Studies, held April 13–14, 1988, was organized by the U.S. EPA's Office of Research and Development and Office of Toxic Substances and was supported by the Agency's Risk Assessment Forum. The purpose of the workshop was to review the current state of knowledge on the use of the dermal route of exposure in developmental toxicity studies. In evaluating this area, three major issues were considered by the participants: (1) the evaluation of maternal toxicity in dermal developmental toxicity studies, (2) what types of pharmacokinetic data are necessary or desirable for the appropriate design and interpretation of these studies, and (3) what factors are important to consider in the design of dermal developmental toxicity studies. The participants concluded: (1) dermal developmental toxicity studies without any indication of maternal or developmental toxicity are inadequate for risk assessment unless accompanied by absorption data, (2) absorption data and limited pharmacokinetic data should be collected in every dermal developmental toxicity study, and (3) dermal developmental toxicity studies in which skin irritation is too marked should be considered inadequate for risk assessment. General recommendations made for all developmental toxicity studies regardless of the route of exposure were: signs of local irritation should be examined, and absorption/pharmacokinetic data should be developed. Areas in which additional research is needed to permit more complete assessment of dermal developmental toxicity studies were also identified.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.